Hormone Health Hub: Expert Insights on Testing, Balance & Better Living — estrogen receptor alpha

Single nucleotide variations (SNVs) in the enzymes that metabolise estrogen can significantly alter breast cancer risk — in some cases by as much as 12-fold when multiple variants combine. In this detailed scientific overview, Jillian Harrington PhD of ZRT Laboratory explains how variations in CYP11A1, CYP19A1 (aromatase), CYP1B1, COMT and MnSOD affect the estrogen metabolism pathway, why catechol estrogens are dangerous, and how methylation testing can reveal individual vulnerability.

Cardiovascular disease is the leading cause of death in women, and the risk dramatically increases with menopause as estrogen levels decline. In this in-depth clinical article, Dr. Sherry LaBeck of ZRT Laboratory explains how estrogen protects the cardiovascular system through nitric oxide production, endothelial function, blood lipid regulation and anti-inflammatory mechanisms — and why the timing of estrogen replacement therapy is critical to its cardioprotective effect.